Scientists on the Japan Advanced Institute of Science and Technology (JAIST) have recognized a naturally occurring bacterium from the intestines of Japanese tree frogs (Dryophytes japonicus) that demonstrated exceptional anticancer exercise in mice. The findings, printed in Gut Microbes, introduce a new method to cancer remedy that makes use of residing micro organism to immediately goal tumors slightly than merely altering the intestine microbiome.
Unlike many earlier research that targeted on altering the composition of intestine micro organism or utilizing fecal microbiota transplants, this analysis remoted particular person bacterial strains, grew them in the laboratory, and delivered them intravenously to assault tumors.
The crew collected 45 bacterial strains from the intestines of Japanese tree frogs, Japanese fireplace stomach newts (Cynops pyrrhogaster), and Japanese grass lizards (Takydromus tachydromoides). After screening the micro organism for anticancer exercise, 9 strains confirmed promise. Among them, Ewingella americana produced the strongest outcomes.
Single Treatment Eliminated Tumors in Mice
In a mouse mannequin of colorectal cancer, a single intravenous dose of E. americana fully eradicated tumors, producing a 100% full response (CR) fee. According to the researchers, the remedy outperformed commonplace therapies used for comparability, together with immune checkpoint inhibitors (anti-PD-L1 antibody) and the chemotherapy drug liposomal doxorubicin.
The researchers emphasize that these findings are restricted to mice, however they consider the outcomes present an encouraging proof of idea for creating new bacterial cancer therapies.
Dual Attack on Cancer Cells
The bacterium seems to combat cancer by way of two complementary mechanisms.
First, E. americana immediately assaults tumors. As a facultative anaerobic bacterium, it thrives in each oxygen wealthy and oxygen poor environments, permitting it to multiply contained in the oxygen disadvantaged areas generally discovered inside tumors. Once there, the bacterial inhabitants elevated by roughly 3,000 fold inside 24 hours after remedy, immediately damaging cancer cells.
Second, the bacterium stimulates the immune system. Its presence attracted T cells, B cells, and neutrophils into tumors. These immune cells then launched inflammatory signaling molecules, together with TNF-α and IFN-γ, which strengthened the immune response and promoted cancer cell dying.
Why the Bacteria Target Tumors
One of probably the most hanging findings was that E. americana accrued virtually solely inside tumors and didn’t colonize wholesome organs.
The researchers consider this tumor specificity outcomes from a number of components working collectively:
- The low oxygen setting inside tumors encourages bacterial progress.
- Cancer cells produce the CD47 protein, which suppresses native immune exercise and creates situations that enable the micro organism to outlive.
- Tumor blood vessels are unusually leaky, making it simpler for micro organism circulating in the bloodstream to enter tumor tissue.
- Tumor particular metabolic adjustments present vitamins that assist bacterial progress.
Together, these traits enable the micro organism to pay attention the place tumors are situated whereas avoiding regular tissues.
Favorable Safety Results
The analysis crew additionally evaluated the remedy’s security.
They discovered that the micro organism had been quickly cleared from the bloodstream, with a half life of roughly 1.2 hours, and have become undetectable inside 24 hours. No bacterial colonization was detected in wholesome organs, together with the liver, spleen, lungs, kidneys, or coronary heart.
The remedy triggered solely delicate, short-term irritation that returned to regular inside 72 hours. During a 60 day statement interval, the researchers discovered no proof of persistent toxicity.
Expanding to Other Types of Cancer
The research establishes proof of idea for utilizing naturally occurring micro organism as a cancer remedy. Future analysis will study whether or not the method could be utilized to extra stable tumors, together with breast cancer, pancreatic cancer, and melanoma.
The crew additionally plans to optimize remedy strategies by way of approaches similar to dose fractionation and direct injection into tumors. Researchers will even examine whether or not E. americana works even higher when mixed with present chemotherapy or immunotherapy.
The findings additionally spotlight the potential worth of exploring biodiversity as a supply of future medical remedies, providing the potential of new therapeutic choices for sufferers with cancers which can be tough to deal with.
Glossary
- Facultative Anaerobic Bacteria: Bacteria able to rising in each oxygen wealthy and oxygen depleted environments, permitting them to selectively multiply in the low oxygen situations discovered inside tumors.
- Complete Response (CR): Complete disappearance of detectable tumors following remedy.
- Immune Checkpoint Inhibitor: Drugs that take away the indicators cancer cells use to suppress the immune system, permitting T cells to assault tumors extra successfully.
- CD47: A protein on the floor of cells that sends a “don’t eat me” sign to the immune system. Many cancer cells produce massive quantities of CD47 to keep away from immune assault.
The analysis was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (A) (Grant No. 23H00551), JSPS KAKENHI Grant-in-Aid for Challenging Research (Pioneering) (Grant No. 22K18440), the JSPS Program for Forming Japan’s Peak Research Universities（J-PEAKS） (Grant No. JPJS00420230006), the Japan Science and Technology Agency (JST) Program for Co-creating Startup Ecosystem (Grant No. JPMJSF2318), and JST SPRING (Grant No. JPMJSP2102).